NCT02928094 - Ad5FGF-4 In Patients With Refractory Angina Due to Myocardial Ischemia | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

March 1, 2024

Study Completion Date

December 31, 2024

Conditions

Angina, Stable

Interventions

BIOLOGICAL

Ad5FGF-4

Ad5FGF-4 administered via intracoronary infusion using standard balloon catheter, and under conditions of transient ischemia.

BIOLOGICAL

Placebo

Placebo buffer administered via intracoronary infusion using standard balloon catheter, without transient ischemia.